Your browser doesn't support javascript.
loading
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove, Leonard S; Lembo, Anthony; Randall, Charles W; Fogel, Ronald; Andrae, David; Davenport, J Michael; McIntyre, Gail; Almenoff, June S; Covington, Paul S.
Affiliation
  • Dove LS; Furiex Pharmaceuticals, Morrisville, North Carolina 27560, USA. scott.dove@furiex.com
Gastroenterology ; 145(2): 329-38.e1, 2013 Aug.
Article in En | MEDLINE | ID: mdl-23583433
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylalanine / Gastrointestinal Agents / Receptors, Opioid, delta / Receptors, Opioid, mu / Irritable Bowel Syndrome / Diarrhea / Imidazoles Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Gastroenterology Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylalanine / Gastrointestinal Agents / Receptors, Opioid, delta / Receptors, Opioid, mu / Irritable Bowel Syndrome / Diarrhea / Imidazoles Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Gastroenterology Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos